Gladwin, M. T., Gordeuk, V. R., Desai, P. C., Minniti, C., Novelli, E. M., Morris, C. R., . . . Abebe, K. Z. (2024). Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): A randomised, double-blind, placebo controlled, phase 1–2 trial. The Lancet Haematology, 11(5), e345. https://doi.org/10.1016/S2352-3026(24)00045-0

Gladwin, Mark T., et al. "Riociguat in Patients with Sickle Cell Disease and Hypertension or Proteinuria (STERIO-SCD): A Randomised, Double-blind, Placebo Controlled, Phase 1–2 Trial." The Lancet Haematology 11, no. 5 (2024): e345. https://doi.org/10.1016/S2352-3026(24)00045-0.

Gladwin, Mark T., et al. "Riociguat in Patients with Sickle Cell Disease and Hypertension or Proteinuria (STERIO-SCD): A Randomised, Double-blind, Placebo Controlled, Phase 1–2 Trial." The Lancet Haematology, vol. 11, no. 5, 2024, p. e345, https://doi.org/10.1016/S2352-3026(24)00045-0.